Generalizability of clinical trial results for bipolar disorder to community samples: Findings from the national epidemiologic survey on alcohol and related conditions

Journal of Clinical Psychiatry

Volumn 74, Issue 3, 2013, Pages 265-270

  Hoertel, Nicolas ^a,b,c   Strat, Yann Le ^b,c,d   Lavaud, Pierre ^b,e   Dubertret, Caroline ^b,c,d   Limosin, Frédéric ^a,b,c  

^a Paris Descartes University   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSERM   (France)

^d HÔPITAL LOUIS MOURIER   (France)

^e BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL ABUSE; ALCOHOLISM; ARTICLE; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CLINICAL TRIAL (TOPIC); COMMUNITY SAMPLE; DSM-IV; GENERALIZABILITY; HUMAN; MAJOR CLINICAL STUDY; MANIA; PATIENT SELECTION; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; STATISTICAL PARAMETERS; SUICIDE;

EID: 84873551510     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.12m07935     Document Type: Article

References (43)

1. Bucher HC, Guyatt GH, Cook DJ, et al; Evidence-Based Medicine Working Group. Users' guides to the medical literature, 29: applying clinical trial results. a: how to use an article measuring the effect of an intervention on surrogate end points. JAMA. 1999;282(8):771-778. (Pubitemid 29404385)
2. Oxman AD, Sackett DL, Guyatt GH. The Evidence-Based Medicine Working Group. Users' guides to the medical literature, 1: how to get started. JAMA. 1993;270(17):2093-2095. (Pubitemid 23318176)
3. Blanco C, Olfson M, Goodwin RD, et al. Generalizability of clinical trial results for major depression to community samples: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2008;69(8):1276-1280.
4. Weisberg HI, Hayden VC, Pontes VP. Selection criteria and generalizability within the counterfactual framework: explaining the paradox of antidepressant-induced suicidality? Clin Trials. 2009;6(2):109-118.
5. Dzewaltowski DA, Estabrooks PA, Klesges LM, et al. Behavior change intervention research in community settings: how generalizable are the results? Health Promot Int. 2004;19(2):235-245. (Pubitemid 38724515)
6. March JS, Silva SG, Compton S, et al. The case for practical clinical trials in psychiatry. Am J Psychiatry. 2005;162(5):836-846. (Pubitemid 40676194)
7. Geddes J, Carney S. Recent advances in evidence-based psychiatry. Can J Psychiatry. 2001;46(5):403-406. (Pubitemid 32652057)
8. Wells KB. Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research. Am J Psychiatry. 1999;156(1):5-10. (Pubitemid 29034873)
9. Licht RW. Limits of the applicability and generalizability of drug trials in mania. Bipolar Disord. 2002;4(suppl 1):66-68.
10. Gaynes BN, Warden D, Trivedi MH, et al. What did STAR*D teach us? results from a large-scale, practical, clinical trial for patients with depression. Psychiatr Serv. 2009;60(11):1439-1445.
11. Zimmerman M, Chelminski I, Posternak MA. Generalizability of antidepressant efficacy trials: differences between depressed psychiatric outpatients who would or would not qualify for an efficacy trial. Am J Psychiatry. 2005;162(7):1370-1372. (Pubitemid 40905589)
12. Zimmerman M, Mattia JI, Posternak MA. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? Am J Psychiatry. 2002;159(3):469-473. (Pubitemid 34184745)
13. Boter H, Derks EM, Fleischhacker WW, et al. Generalizability of the results of efficacy trials in first-episode schizophrenia: comparisons between subgroups of participants of the European First Episode Schizophrenia Trial (EUFEST). J Clin Psychiatry. 2010;71(1):58-65.
14. Leucht S, Heres S, Hamann J, et al. Methodological issues in current antipsychotic drug trials. Schizophr Bull. 2008;34(2):275-285. (Pubitemid 351323339)
15. Khan AY, Preskorn SH, Baker B. Effect of study criteria on recruitment and generalizability of the results. J Clin Psychopharmacol. 2005;25(3):271-275. (Pubitemid 40685794)
16. Blanco C, Olfson M, Okuda M, et al. Generalizability of clinical trials for alcohol dependence to community samples. Drug Alcohol Depend. 2008;98(1-2):123-128.
17. Humphreys K, Weingardt KR, Harris AH. Influence of subject eligibility criteria on compliance with National Institutes of Health guidelines for inclusion of women, minorities, and children in treatment research. Alcohol Clin Exp Res. 2007;31(6):988-995. (Pubitemid 46776177)
18. Humphreys K, Weingardt KR, Horst D, et al. Prevalence and predictors of research participant eligibility criteria in alcohol treatment outcome studies, 1970-98. Addiction. 2005;100(9):1249-1257. (Pubitemid 41248066)
19. Okuda M, Hasin DS, Olfson M, et al. Generalizability of clinical trials for cannabis dependence to community samples. Drug Alcohol Depend. 2010;111(1-2):177-181.
20. Le Strat Y, Rehm J, Le Foll B. How generalisable to community samples are clinical trial results for treatment of nicotine dependence: a comparison of common eligibility criteria with respondents of a large representative general population survey. Tob Control. 2011;20(5):338-343.
21. Hoertel N, Le Strat Y, De Maricourt P, et al. Are subjects in treatment trials of panic disorder representative of patients in routine clinical practice? results from a national sample [published online ahead of print October 17, 2012]. J Affect Disord.
22. Westen D, Morrison K. A multidimensional meta-analysis of treatments for depression, panic, and generalized anxiety disorder: an empirical examination of the status of empirically supported therapies. J Consult Clin Psychol. 2001;69(6):875-899. (Pubitemid 33140488)
23. Hoertel N, Le Strat Y, Blanco C, et al. Generalizability of clinical trial results for generalized anxiety disorder to community samples. Depress Anxiety. 2012;29(7):614-620.
24. Zarin DA, Young JL, West JC. Challenges to evidence-based medicine: a comparison of patients and treatments in randomized controlled trials with patients and treatments in a practice research network. Soc Psychiatry Psychiatr Epidemiol. 2005;40(1):27-35. (Pubitemid 40069169)
25. Grant BF, Dawson DA, Stinson FS, et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend. 2003;71(1):7-16. (Pubitemid 36734856)
26. Grant BF, Dawson DA, Stinson FS, et al. The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002. Drug Alcohol Depend. 2004;74(3):223-234. (Pubitemid 38759777)
27. Grant BF, Harford TC, Dawson DA, et al. The Alcohol Use Disorder and Associated Disabilities Interview schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample. Drug Alcohol Depend. 1995;39(1):37-44.
28. Hasin D, Carpenter KM, McCloud S, et al. The alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a clinical sample. Drug Alcohol Depend. 1997;44(2-3):133-141. (Pubitemid 27129506)
29. Canino G, Bravo M, Ramírez R, et al. The Spanish Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): reliability and concordance with clinical diagnoses in a Hispanic population. J Stud Alcohol. 1999;60(6):790-799. (Pubitemid 29526544)
30. Grant BF, Stinson FS, Dawson DA, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61(8):807-816. (Pubitemid 39031120)
31. Hasin DS, Stinson FS, Ogburn E, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2007;64(7):830-842. (Pubitemid 47026379)
32. Frye MA. Clinical practice: bipolar disorder - a focus on depression. N Engl J Med. 2011;364(1):51-59.
33. Cipriani A, Barbui C, Salanti G, et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet. 2011;378(9799):1306-1315.
34. Team. RDC. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0. http://www.R-project.org. 2008. Accessed October 5, 2012.
35. Blazer DG 2nd, Hybels CF. Origins of depression in later life. Psychol Med. 2005;35(9):1241-1252. (Pubitemid 41264304)
36. Goldenberg IM, White K, Yonkers K, et al. The infrequency of "pure culture" diagnoses among the anxiety disorders. J Clin Psychiatry. 1996;57(11):528-533. (Pubitemid 26412505)
37. Cohen P, Cohen J. The clinician's illusion. Arch Gen Psychiatry. 1984;41(12):1178-1182. (Pubitemid 15215485)
38. Kirchner JE, Booth BM, Owen RR, et al. Predictors of patient entry into alcohol treatment after initial diagnosis. J Behav Health Serv Res. 2000;27(3):339-346. (Pubitemid 30485801)
39. Oquendo MA, Currier D, Liu SM, et al. Increased risk for suicidal behavior in comorbid bipolar disorder and alcohol use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J Clin Psychiatry. 2010;71(7):902-909.
40. Verdoux H, Bégaud B. Pharmaco-epidemiology: what do (and don't) we know about utilisation and impact of psychotropic medications in real-life conditions? Br J Psychiatry. 2004;185(2):93-94. (Pubitemid 39061449)
41. Hasin DS, Goodwin RD, Stinson FS, et al. Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry. 2005;62(10):1097-1106. (Pubitemid 41396935)
42. Hoertel N, Le Strat Y, Angst J, et al. Subthreshold bipolar disorder in a US national representative sample: prevalence, correlates and perspectives for psychiatric nosography. [published online ahead of print October 3, 2012.] J Affect Disord.
43. Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617-627. (Pubitemid 40973437)